Nucleic Acids Research, 2000, Vol. 28, No. 21 4113-4124
© 2000 Oxford University Press
Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes
The Biotechnology Centre of Oslo, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway, 1Department of Chemistry, Carlsberg Laboratory, Gamle Carlsberg Vej 10, DK-2500 Valby, Denmark and 2Institut für Organische Chemie, Universität Göttingen, Tammann strasse 2, 37077 Göttingen, Germany
We have investigated the relative merits of two commonly used methods for target site selection for ribozymes: secondary structure prediction (MFold program) and in vitro accessibility assays. A total of eight methylated ribozymes with DNA arms were synthesized and analyzed in a transient co-transfection assay in HeLa cells. Residual expression levels ranging from 23 to 72% were obtained with anti-PSKH1 ribozymes compared to cells transfected with an irrelevant control ribozyme. Ribozyme efficacy depended on both ribozyme concentration and the steady state expression levels of the target mRNA. Allylated ribozymes against a subset of the target sites generally displayed poorer efficacy than their methylated counterparts. This effect appeared to be influenced by in vivo accessibility of the target site. Ribozymes designed on the basis of either selection method displayed a wide range of efficacies with no significant differences in the average activities of the two groups of ribozymes. While in vitro accessibility assays had limited predictive power, there was a significant correlation between certain features of the predicted secondary structure of the target sequence and the efficacy of the corresponding ribozyme. Specifically, ribozyme efficacy appeared to be positively correlated with the presence of short stem regions and helices of low stability within their target sequences. There were no correlations with predicted free energy or loop length.
* To whom correspondence should be addressed. Tel: +47 2295 8755; Fax: +47 2269 4130; Email: hans.prydz@biotek.uio.no
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Jagannath and M. Wood RNA interference based gene therapy for neurological disease Brief Funct Genomic Proteomic, May 3, 2007; (2007) elm005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Du, H. Thonberg, J. Wang, C. Wahlestedt, and Z. Liang A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites Nucleic Acids Res., March 21, 2005; 33(5): 1671 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Deocaris, S. C. Kaul, K. Taira, and R. Wadhwa Emerging Technologies: Trendy RNA Tools for Aging Research J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): B771 - B783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Boden, O. Pusch, F. Lee, L. Tucker, P. R. Shank, and B. Ramratnam Promoter choice affects the potency of HIV-1 specific RNA interference Nucleic Acids Res., September 1, 2003; 31(17): 5033 - 5038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kretschmer-Kazemi Far and G. Sczakiel The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides Nucleic Acids Res., August 1, 2003; 31(15): 4417 - 4424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Holen, M. Amarzguioui, E. Babaie, and H. Prydz Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway Nucleic Acids Res., May 1, 2003; 31(9): 2401 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Amarzguioui, T. Holen, E. Babaie, and H. Prydz Tolerance for mutations and chemical modifications in a siRNA Nucleic Acids Res., January 15, 2003; 31(2): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Bergeron and J.-P. Perreault Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus Nucleic Acids Res., November 1, 2002; 30(21): 4682 - 4691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Smith, C. M. Walton, C. H. Wu, and G. Y. Wu Secondary Structure and Hybridization Accessibility of Hepatitis C Virus 3'-Terminal Sequences J. Virol., August 28, 2002; 76(19): 9563 - 9574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Holen, M. Amarzguioui, M. T. Wiiger, E. Babaie, and H. Prydz Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor Nucleic Acids Res., April 15, 2002; 30(8): 1757 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kurreck, B. Bieber, R. Jahnel, and V. A. Erdmann Comparative Study of DNA Enzymes and Ribozymes against the Same Full-length Messenger RNA of the Vanilloid Receptor Subtype I J. Biol. Chem., February 22, 2002; 277(9): 7099 - 7107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Mir, T. J. Lockett, and P. Hendry Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers Nucleic Acids Res., May 1, 2001; 29(9): 1906 - 1914. [Abstract] [Full Text] [PDF]
|
|